companydirectorylist.com  Global Business Directories and Company Directories
Search Business,Company,Industry :


Country Lists
USA Company Directories
Canada Business Lists
Australia Business Directories
France Company Lists
Italy Company Lists
Spain Company Directories
Switzerland Business Lists
Austria Company Directories
Belgium Business Directories
Hong Kong Company Lists
China Business Lists
Taiwan Company Lists
United Arab Emirates Company Directories


Industry Catalogs
USA Industry Directories












Company Directories & Business Directories

ASCO POWER TECHNOLOGIES CANADA

PORT COQUITLAM-Canada

Company Name:
Corporate Name:
ASCO POWER TECHNOLOGIES CANADA
Company Title:  
Company Description:  
Keywords to Search:  
Company Address: 2071 Kingsway Ave,PORT COQUITLAM,BC,Canada 
ZIP Code:
Postal Code:
V3C 
Telephone Number: 6049446776 
Fax Number: 6044682445 
Website:
 
Email:
 
USA SIC Code(Standard Industrial Classification Code):
244770 
USA SIC Description:
VALVES & FITTINGS 
Number of Employees:
 
Sales Amount:
$500,000 to $1 million 
Credit History:
Credit Report:
Good 
Contact Person:
 
Remove my name



copy and paste this google map to your website or blog!

Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples:
WordPress Example, Blogger Example)









Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer

(Any information to deal,buy, sell, quote for products or service)

Your Subject:
Your Comment or Review:
Security Code:



Previous company profile:
ASHBURY LANE WINDOW FASHIONS
ASCOT FINANCIAL SVC LTD
ASCOT FINANCIAL SERVICES LIMITE
Next company profile:
ASAHI JAPANESE RESTAURANT
AS NEW AUTOBODY & GLASS LTD
AS NEW AUTOBODY & GLASS










Company News:
  • ASCO Annual Meeting - ASCO
    Were you unable to attend the 2025 ASCO Annual Meeting? Access all five days of practice-changing science, cutting-edge research, and meeting content by purchasing the slides and videos
  • American Society of Clinical Oncology - ASCO
    The tool can help you to more quickly navigate ASCO’s full library of clinical practice guidelines; make faster, evidence-based clinical decisions with clear citations and sources; and quickly and easily ask follow-up questions
  • ASCO Meetings
    2025 ASCO Annual Meeting View the abstracts, videos, slides and posters presented at the 2025 ASCO Annual Meeting
  • ASCO Overview - ASCO
    ASCO Promotes and Provides For Lifelong learning for oncology professionals, Cancer research, An improved environment for oncology practice, Access to quality cancer care, A global network of oncology expertise, and Educated and informed patients with cancer
  • Membership - ASCO
    The American Society of Clinical Oncology and the Association for Clinical Oncology (collectively, ASCO) offer membership for all members of the cancer care team, giving everyone access to the same resources, products, and publications to provide the most comprehensive care
  • Program Guide – ASCO Meeting Program Guide
    ASCO Breakthrough is your gateway to up-to-the-minute clinical research advances across multiple disease sites Uncover how global knowledge-sharing translates to high-quality care for all people affected by cancer worldwide
  • Guidelines - ASCO
    ASCO Guidelines provide evidence-based recommendations and outline appropriate methods of treatment and care for clinicians The guidelines address specific clinical situations (disease-oriented) or the use of approved medical products, procedures, or tests (modality-oriented)
  • ASCO – American Society of Clinical Oncology
    About ASCO Contact Us Licensing ASCO Overview Press Center Careers at ASCO Mobile Apps Conference Center Rental Association for Clinical Oncology
  • Program - ASCO
    Program The 2025 ASCO Annual Meeting is The Place to Be Learn more about the sessions, speakers, and science that will be presented at this year's meeting below
  • Abstracts - ASCO
    Long-term outcomes and overall survival (OS) for zanidatamab + chemotherapy in HER2-positive (HER2+) advanced or metastatic gastroesophageal adenocarcinoma (mGEA): 4-year follow-up of a phase 2 trial




Business Directories,Company Directories
Business Directories,Company Directories copyright ©2005-2012 
disclaimer